These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 14186516)

  • 21. The action of bromosalicylhydroxamic acid (T40) on the biological level of INH and on the emergence of INH-resistant bacilli in combined treatment of tuberculosis.
    HORNUNG S; POLONCZYK M; DRAJKA-KROPACZEK L; RAPF T
    Acta Tuberc Pneumol Scand; 1962; 42():233-9. PubMed ID: 13954963
    [No Abstract]   [Full Text] [Related]  

  • 22. [CLINICAL EXPERIENCE WITH D.A.T.C].
    LAPERUTA AM; EQUIOIZ LP; SILVA GA
    Sem Med; 1964 Apr; 124():843-6. PubMed ID: 14181017
    [No Abstract]   [Full Text] [Related]  

  • 23. [ANTITUBERCULOUS ACTIVITY OF DEXTRO-2,2'-(ETHYLENEDIIMINO)-DI-1-BUTANOL (ETHAMBUTOL). (II) COMBINED EFFECT OF ETHAMBUTOL AND ISONIAZID].
    MORIYAMA E
    Kekkaku; 1964 Jun; 39():191-6. PubMed ID: 14173350
    [No Abstract]   [Full Text] [Related]  

  • 24. [ON THE PROBLEM OF DOSAGE IN INH THERAPY].
    FODOR T
    Tuberk Tudobetegsegek; 1964 Jun; 17():182-4. PubMed ID: 14190272
    [No Abstract]   [Full Text] [Related]  

  • 25. [EFFECT OF SO-CALLED SECONDARY ANTIBACTERIAL AGENTS ON PULMONARY TUBERCULOSIS].
    JANCIK E
    Bibl Tuberc; 1964; 19():121-218. PubMed ID: 14271074
    [No Abstract]   [Full Text] [Related]  

  • 26. [ON THE INCIDENCE OF PRIMARY DRUG RESISTANCE IN PATIENTS WITH PULMONARY TUBERCULOSIS].
    KANTARBAEVA ZK; BLONSKAIA LI; KRIVTSOVA AI
    Probl Tuberk; 1963; 41():33-5. PubMed ID: 14108759
    [No Abstract]   [Full Text] [Related]  

  • 27. THE CLINICAL SIGNIFICANCE OF LOW DEGREES OF DRUG RESISTANCE IN PULMONARY TUBERCULOSIS.
    STEWART SM; CROFTON JW
    Am Rev Respir Dis; 1964 Jun; 89():811-29. PubMed ID: 14169411
    [No Abstract]   [Full Text] [Related]  

  • 28. [ANTIMICROBIAL SCREEN IN PHTHISIOLOGICAL SURGERY].
    SNAJDR V; KRAKORA P; FISER F; CHODOUNSKA V
    Rozhl Chir; 1963 Oct; 42():712-20. PubMed ID: 14119837
    [No Abstract]   [Full Text] [Related]  

  • 29. [RETROSPECTIVE ANALYSIS OF CAUSES OF SECONDARY DRUG-RESISTANCE IN PULMONARY TUBERCULOSIS PATIENTS].
    WAGNER J
    Gruzlica (1926); 1964 Aug; 32():655-61. PubMed ID: 14195490
    [No Abstract]   [Full Text] [Related]  

  • 30. [EXPERIMENTAL STUDIES ON EFFECT OF COMBINED USE OF 1314TH AND INH TO INH-RESISTANT TUBERCLE BACILLI. 2. COMBINATION EFFECT IN THE EXPERIMENTAL TUBERCULOSIS OF MICE].
    NOZAKI T
    Kekkaku; 1964 Jun; 39():223-7. PubMed ID: 14173355
    [No Abstract]   [Full Text] [Related]  

  • 31. Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands.
    van Soolingen D; de Haas PE; van Doorn HR; Kuijper E; Rinder H; Borgdorff MW
    J Infect Dis; 2000 Dec; 182(6):1788-90. PubMed ID: 11069256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [INFORMATION ON A NEW TECHNIQUE FOR ANTITUBERCULOSIS THERAPY].
    CASTELLARIERA J; GRANENAFUGUET P; COLLCOLOME F
    Folia Clin Int (Barc); 1964 Mar; 14():152-60. PubMed ID: 14156917
    [No Abstract]   [Full Text] [Related]  

  • 33. [TREATMENT OF 140 PATIENTS HAVING BACILLI RESISTANT TO INH AND STREPTOMYCIN].
    CHICOU J
    Rev Tuberc Pneumol (Paris); 1964; 28():825-31. PubMed ID: 14236397
    [No Abstract]   [Full Text] [Related]  

  • 34. RETREATMENT OF PULMONARY TUBERCULOSIS IN PATIENTS WITH BACILLI RESISTANT TO MAJOR DRUGS. OPTIMAL REGIMENS.
    ZIERSKI M
    Bull Int Union Tuberc; 1964 Sep; 35():173-8. PubMed ID: 14269368
    [No Abstract]   [Full Text] [Related]  

  • 35. THE CHANGING PICTURE OF TUBERCULOSIS.
    PFUETZE KH; PISZCZEK EA; HALL C
    Dis Chest; 1965 Apr; 47():392-7. PubMed ID: 14272538
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug-resistant tuberculosis in Budapest.
    Fodor T; Vadász I; Lõrinczi I
    Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ANNUAL CHANGE OF DRUG RESISTANCE CASES VIEWED THROUGH A JAPANESE NATIONAL SANATORIUM.
    TSUKAMURA M
    Acta Tuberc Pneumol Scand; 1964; 45():149-53. PubMed ID: 14215787
    [No Abstract]   [Full Text] [Related]  

  • 38. [FAILURE OF INH THERAPY IN TUBERCULOTICS CONTINUING TO EXPECTORATE BACILLI UNALTERABLY SENSITIVE TO ISONIAZID].
    COURTOIS R
    Acta Tuberc Pneumol Belg; 1964; 55():9-20. PubMed ID: 14175176
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of INH- and streptomycin-resistant patients].
    Böszörményi M; Schweiger O
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):329-31. PubMed ID: 5897861
    [No Abstract]   [Full Text] [Related]  

  • 40. [THE RELATIONSHIP OF CHANGES IN THE AMOUNT OF DISCHARGED TUBERCLE BACILLI TO ITS DRUG RESISTANCE. A STUDY OF SIGNIFICANCE OF THE RESISTANCE TEST IN CASES WHICH DISCHARGE TUBERCLE BACILLI SLIGHTLY].
    HAGIHARA T; OKAYASU M; KAWAMURA A; OGAWA M
    Kekkaku; 1964 Dec; 39():532-6. PubMed ID: 14270665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.